ARTICLE
|
doi:10.20944/preprints202305.1353.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
gliomas; temozolomide; resistance; genes; PIK3C2B; ERBB3; KIT; MLH1; MGMT
Online: 18 May 2023 (14:59:42 CEST)